MENU
+Compare
SRDX
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$34.85
Change
+$0.47 (+1.37%)
Capitalization
397.04M

SRDX Surmodics Forecast, Technical & Fundamental Analysis

a provider of surface modification and in vitro diagnostic technologies to the healthcare industry

SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SRDX with price predictions
Feb 21, 2025

SRDX's RSI Indicator climbs out of oversold territory

The RSI Oscillator for SRDX moved out of oversold territory on February 10, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 38 similar instances when the indicator left oversold territory. In of the 38 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 14, 2025. You may want to consider a long position or call options on SRDX as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SRDX just turned positive on February 14, 2025. Looking at past instances where SRDX's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRDX advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for SRDX moved below the 200-day moving average on February 05, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SRDX broke above its upper Bollinger Band on February 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SRDX entered a downward trend on February 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SRDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.250) is normal, around the industry mean (23.448). P/E Ratio (71.513) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.838) is also within normal values, averaging (41.230).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SRDX is expected to report earnings to rise 116.75% to -8 cents per share on April 30

Surmodics SRDX Stock Earnings Reports
Q1'25
Est.
$-0.09
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.42
The last earnings report on January 30 showed earnings per share of -3 cents, beating the estimate of -11 cents. With 271.37K shares outstanding, the current market capitalization sits at 397.04M.
A.I. Advisor
published General Information

General Information

a provider of surface modification and in vitro diagnostic technologies to the healthcare industry

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9924 West 74th Street
Phone
+1 952 500-7000
Employees
376
Web
https://www.surmodics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NUGCX35.15-0.31
-0.87%
Nuveen Global Dividend Growth C
RSQCX13.20-0.23
-1.71%
Royce Small-Cap Special Equity Consult
ETEGX15.43-0.28
-1.78%
Eaton Vance Small-Cap A
MRERX49.92-0.92
-1.81%
MFS Core Equity R2
WICVX9.85-0.27
-2.67%
Wasatch Small Cap Value Institutional

SRDX and Stocks

Correlation & Price change

A.I.dvisor tells us that SRDX and RMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRDX and RMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
+1.37%
RMD - SRDX
32%
Poorly correlated
-0.47%
LIVN - SRDX
31%
Poorly correlated
-1.15%
MBOT - SRDX
26%
Poorly correlated
-7.02%
UFPT - SRDX
26%
Poorly correlated
-4.66%
VNRX - SRDX
26%
Poorly correlated
-4.13%
More